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Hodgkin Lymphoma
• Immune system support
• Lymph
• Lymphocytes + other white blood cells
• Antibodies
• Nutrients
http://drfogelman.com/wp-content/uploads/2010/11/Lymphatic-1.gif
https://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/?region=on
Apoptosis
http://www.curcumine-sante.net/wp-content/uploads/2014/03/apoptose_cellulaire.jpg
Cancer Treatment: Options
• Surgery
Hodgkin 
Lymphoma:
• Radiation 
therapy
• Chemotherapy
http://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/treatment/?region=bc
http://www.joshgitalis.com/pre-and-post-surgery-nutrition/
http://www.dailymail.co.uk/health/article-1177248/New-scans-reveal-chemotherapy-working.html
http://www.onclive.com/web-exclusives/Radiation-Therapy-After-Surgery-Shows-No-Survival-Benefit-for-Elderly-Lung-Cancer-Patients
Turmeric & Rooibos
• Natural health products - new cancer treatment options?
• Strong anti-inflammatory 
agent
• Supports immune system
• Activates intrinsic apoptosis
Turmeric
• Inhibitor of x-ray-induced cell 
transformation
• Anti-oxidant activity
• Free-radical scavengers, like 
flavonoids, induce apoptosis in 
cancerous cells
Rooibos
Bielak-Zmijewska, Anna, et al., (2009) ScienceDirect
Komatsu, Kenshi, et al., (1994) Elsevier Ireland Ltd.
Erickson, Laurie, (2003) The Journal of the American Botanical Council
http://www.healingthebody.ca/healing-benefits-of-turmeric/
http://www.medicinehunter.com/sites/default/files/rooibos_main.jpg?1332955889
Methods of Extraction
• 3 solvents
• Whole, complex mixture
http://s3.amazonaws.com/forums.content.luxology.com/images/poster/a1ec46afc015c868968522e8217463a8_p.jpg
http://i.stack.imgur.com/ysulU.jpg
https://www.kjmagnetics.com/images/blog/BeakerBiglLG.jpg
Hot Water Cold Water Ethanol
Do the anti-proliferative properties of turmeric and 
rooibos extracts in cancer cells translate to Hodgkin 
lymphoma cells, and if they do, is the mechanism of 
action selective?
Assess toxicity 
and efficacy in 
vivo
Discover the 
mode of 
action
Determine 
selective 
cytotoxicity
Do the anti-proliferative properties of turmeric 
and rooibos extracts in cancer cells translate to 
Hodgkin lymphoma cells, and if they do, is the 
mechanism of action selective?
OBJECTIVES
1. Determine if turmeric and rooibos extracts, both individually 
and in combination, exhibit cytotoxic effects against Hodgkin 
Lymphoma cells (WST-1 assay)
2. Quantify cytotoxicity (Trypan blue exclusion assay)
3. Determine permanency of the drugs’ effects (Revival assay)
Determine 
selective 
cytotoxicity
1.   Determining cytotoxicity
• WST-1 Assay
https://i.ytimg.com/vi/7u7cMZyKG9E/hqdefault.jpg
http://www.clontech.com/IE/Support/Applications/Cell_Biology/ibcGetAttachment.jsp?cItemId=54709
Lower absorbance 
=
Lower viability
Cold Water Hot Water
Ethanol (Unfiltered) Ethanol (Filtered)
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• Trypan blue exclusion assay
2.   Quantify cytotoxicity
http://www.graymed.com.au/image/data/LW/Lab/hemacytometer_lge.jpg
http://tools.thermofisher.com/content/sfs/prodImages/high/15250-061_650X600.jpg
dead
dead
dead
live
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2. Quantify cytotoxicity:
Effect of ethanolic turmeric extract on the viability of 
KM-H2 cells
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2. Quantify cytotoxicity:
Effect of rooibos extracts on the viability of KM-H2 cells
Cold water rooibos Hot water rooibos
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2. Quantify cytotoxicity:
Effect of extracts in combination on the viability of 
KM-H2 cells
Cold water combination Hot water combination
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3.   Determine permanency of the drugs’ effects
• Revival assay
Ineffective drug/
Control
Semi-effective
drug
Effective drug
48 hours 48h 72h 96h24h
Growth of KM-H2 cells in various treatment groups: 
PRELIMINARY RESULTS
48 hours (with drug) 24-72 hours (without drug)
Conclusions
• Turmeric: ethanolic extracts exhibit anti-proliferative effects on 
Hodgkin lymphoma cells that are likely long-lasting
• Rooibos: hot water extracts show cytotoxicity against Hodgkin 
lymphoma cells
• A combinatorial effect exists when low doses of ethanolic
turmeric and cold/hot water rooibos extracts are used together
These natural health products show potential to be 
studied further for the development of more 
effective chemotherapeutic agents.
Future Work
• Assess selectivity of extracts by studying 
cytotoxicity in normal lymphocytes
• Evaluate the mode of cell death induction
• Assess toxicity and efficacy alone and in 
combination in animal models
Dedication
• Dedicated to the memory of Kevin Couvillon, who lost his 
battle against Leukaemia in 2010.
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